Hangzhou Refena Instrument and Device Co., ltd – Trademark Portfolio

Entity Type: 99

Hangzhou Refena Instrument and Device Co., ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 19 (Building Materials) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include REFENA. The owner is based in Hangzhou.

Room 1015, Qiansheng Commercial Building

Hangzhou 311200 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

REFENA
REFENA
Registered 2023

Trademark Classifications

Hangzhou Refena Instrument and Device Co., ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

19
Building Materials (1 filing)

Building materials (non-metallic); non-metallic rigid pipes for building

Frequently Asked Questions

How many trademarks does Hangzhou Refena Instrument and Device Co., ltd have?

Hangzhou Refena Instrument and Device Co., ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Hangzhou Refena Instrument and Device Co., ltd file in?

Hangzhou Refena Instrument and Device Co., ltd files trademarks across 1 Nice Classification class. The most active classes are Class 19 (Building Materials). Class 19 covers building materials (non-metallic); non-metallic rigid pipes for building.

What are Hangzhou Refena Instrument and Device Co., ltd's most well-known trademarks?

Hangzhou Refena Instrument and Device Co., ltd's registered trademark portfolio includes well-known marks such as REFENA. These are among 1 currently registered trademark in the portfolio.

What is Hangzhou Refena Instrument and Device Co., ltd's trademark registration success rate?

Hangzhou Refena Instrument and Device Co., ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.